Digoxin Beneficial for Infants Palliated With Stage 1 Hybrid Procedure
By Elana Gotkine HealthDay Reporter
THURSDAY, Jan. 4, 2024 -- For infants palliated with a stage 1 hybrid procedure, digoxin prescription at discharge is associated with a reduced risk for interstage death or transplant, according to a study recently published in the Journal of the American Heart Association.
Reshma K. Reddy, M.D., from the Shawn Jenkins Children's Hospital at the Medical University of South Carolina in Charleston, and colleagues conducted a retrospective multicenter cohort study using data from the National Pediatric Cardiology Quality Improvement Collaborative registry from 2008 to 2021 to examine whether digoxin prescription at discharge was associated with improved transplant-free interstage survival in infants following hybrid stage 1 palliation. A total of 259 infants were included from 45 sites; 61 percent had hypoplastic left heart syndrome.
Fifty percent of the infants were discharged on digoxin. The researchers found that 23 and 14 percent of patients in the no-digoxin and digoxin groups, respectively, had interstage death or transplant. Discharge digoxin prescription was associated with a reduced risk for interstage death or transplant in a multivariate analysis (adjusted odds ratio, 0.48).
"Based on these findings, it is reasonable to consider prescribing digoxin to infants who have undergone the stage 1 palliation hybrid procedure," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted January 2024
Read this next
Cardiorespiratory Fitness Cuts Risk for Poor Cardiovascular Disease Outcomes
WEDNESDAY, May 8, 2024 -- There is consistent evidence that high cardiorespiratory fitness (CRF) is strongly associated with a lower risk for a variety of cardiovascular disease...
Fetal Medicine Foundation Algorithm Can Predict Preeclampsia
WEDNESDAY, May 8, 2024 -- The first-trimester Fetal Medicine Foundation (FMF) screening test predicts 63.1 percent of preterm preeclampsia cases and 77.3 percent of early-onset...
Excess Gestational Weight Gain Common in Military Health Beneficiaries
TUESDAY, May 7, 2024 -- Military health beneficiaries, especially active-duty personnel, more often have excessive gestational weight gain (GWG), according to a study published in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.